Today NICE announced that they have agreed to fund Venetocolax plus obinutuzamab for all first line patients with CLL who want to take it in England. This means that nobody will be forced to face the choice of agreeing to take FCR chemotherapy or receive no treatment. Does this mean the end of FCR which … Continue reading Venetoclax and obinutuzumab funded in England by NICE, acalabrutinib licensed- the end of FCR chemotherapy for CLL?